266 related articles for article (PubMed ID: 25981591)
21. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
[TBL] [Abstract][Full Text] [Related]
22. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
[TBL] [Abstract][Full Text] [Related]
23. CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer.
Norton JA; Ham CM; Van Dam J; Jeffrey RB; Longacre TA; Huntsman DG; Chun N; Kurian AW; Ford JM
Ann Surg; 2007 Jun; 245(6):873-9. PubMed ID: 17522512
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
Corso G; Pedrazzani C; Pinheiro H; Fernandes E; Marrelli D; Rinnovati A; Pascale V; Seruca R; Oliveira C; Roviello F
Eur J Cancer; 2011 Mar; 47(4):631-9. PubMed ID: 21106365
[TBL] [Abstract][Full Text] [Related]
25. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer.
Kaurah P; MacMillan A; Boyd N; Senz J; De Luca A; Chun N; Suriano G; Zaor S; Van Manen L; Gilpin C; Nikkel S; Connolly-Wilson M; Weissman S; Rubinstein WS; Sebold C; Greenstein R; Stroop J; Yim D; Panzini B; McKinnon W; Greenblatt M; Wirtzfeld D; Fontaine D; Coit D; Yoon S; Chung D; Lauwers G; Pizzuti A; Vaccaro C; Redal MA; Oliveira C; Tischkowitz M; Olschwang S; Gallinger S; Lynch H; Green J; Ford J; Pharoah P; Fernandez B; Huntsman D
JAMA; 2007 Jun; 297(21):2360-72. PubMed ID: 17545690
[TBL] [Abstract][Full Text] [Related]
26. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer.
Oliveira C; Pinheiro H; Figueiredo J; Seruca R; Carneiro F
Prog Mol Biol Transl Sci; 2013; 116():337-59. PubMed ID: 23481202
[TBL] [Abstract][Full Text] [Related]
27. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
[TBL] [Abstract][Full Text] [Related]
28. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
Benusiglio PR; Malka D; Rouleau E; De Pauw A; Buecher B; Noguès C; Fourme E; Colas C; Coulet F; Warcoin M; Grandjouan S; Sezeur A; Laurent-Puig P; Molière D; Tlemsani C; Di Maria M; Byrde V; Delaloge S; Blayau M; Caron O
J Med Genet; 2013 Jul; 50(7):486-9. PubMed ID: 23709761
[TBL] [Abstract][Full Text] [Related]
29. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
30. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
[TBL] [Abstract][Full Text] [Related]
31. [From gene to disease; E-cadherin and hereditary diffuse gastric cancer].
de Bruin JH; Ligtenberg MJ; Nagengast FM; van Krieken JH
Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2474-7. PubMed ID: 14708213
[TBL] [Abstract][Full Text] [Related]
32. Germline CDH1 mutations in bilateral lobular carcinoma in situ.
Petridis C; Shinomiya I; Kohut K; Gorman P; Caneppele M; Shah V; Troy M; Pinder SE; Hanby A; Tomlinson I; Trembath RC; Roylance R; Simpson MA; Sawyer EJ
Br J Cancer; 2014 Feb; 110(4):1053-7. PubMed ID: 24366306
[TBL] [Abstract][Full Text] [Related]
33. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain.
Rodriguez-Sanjuan JC; Fontalba A; Mayorga M; Bordin MC; Hyland SJ; Trugeda S; Garcia RA; Gomez-Fleitas M; Fernandez F; Caldas C; Fernandez-Luna JL
Eur J Surg Oncol; 2006 Dec; 32(10):1110-3. PubMed ID: 16870389
[TBL] [Abstract][Full Text] [Related]
35. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families.
Humar B; Toro T; Graziano F; Müller H; Dobbie Z; Kwang-Yang H; Eng C; Hampel H; Gilbert D; Winship I; Parry S; Ward R; Findlay M; Christian A; Tucker M; Tucker K; Merriman T; Guilford P
Hum Mutat; 2002 May; 19(5):518-25. PubMed ID: 11968084
[TBL] [Abstract][Full Text] [Related]
36. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
37. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
[TBL] [Abstract][Full Text] [Related]
38. [Germline E-cadherin gene mutation screening in familial gastric cancer kindreds].
Jiang Y; Wan YL; Wang ZJ; Zhao B; Zhu J; Huang YT
Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(15):914-7. PubMed ID: 15363252
[TBL] [Abstract][Full Text] [Related]
39. Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer.
Melo S; Figueiredo J; Fernandes MS; Gonçalves M; Morais-de-Sá E; Sanches JM; Seruca R
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29231860
[TBL] [Abstract][Full Text] [Related]
40. The germline CDH1 c.48 G>C substitution contributes to cancer predisposition through generation of a pro-invasive mutation.
Zhang L; Xiao A; Ruggeri J; Bacares R; Somar J; Melo S; Figueiredo J; Simões-Correia J; Seruca R; Shah MA
Mutat Res; 2014 Dec; 770():106-11. PubMed ID: 25771876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]